AAAAAA

   
Results: 1-7 |
Results: 7

Authors: GJEDDE SB HANSEN MM
Citation: Sb. Gjedde et Mm. Hansen, SALVAGE THERAPY WITH FLUDARABINE IN PATIENTS WITH PROGRESSIVE B-CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 21(3-4), 1996, pp. 317-320

Authors: BASTHOLT L DALMARK M GJEDDE SB PFEIFFER P PEDERSEN D SANDBERG E KJAER M MOURIDSEN HT ROSE C NIELSEN OS JAKOBSEN P BENTZEN SM
Citation: L. Bastholt et al., DOSE-RESPONSE RELATIONSHIP OF EPIRUBICIN IN THE TREATMENT OF POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER - A RANDOMIZED STUDY OF EPIRUBICIN AT 4 DIFFERENT DOSE LEVELS PERFORMED BY THE DANISH BREAST-CANCER COOPERATIVE GROUP, Journal of clinical oncology, 14(4), 1996, pp. 1146-1155

Authors: GJEDDE SB MOURIDSEN HT LMADSEN E JENSEN NV BLOMQUIST E BERGH J SODERBERG M WAHLBY S
Citation: Sb. Gjedde et al., PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA, European journal of cancer, 30A(4), 1994, pp. 566-566

Authors: JAKOBSEN P SORENSEN B BASTHOLT L MIRZA MR GJEDDE SB MOURIDSEN HT ROSE C
Citation: P. Jakobsen et al., THE PHARMACOKINETICS OF HIGH-DOSE EPIRUBICIN AND OF THE CARDIOPROTECTOR ADR-529 GIVEN TOGETHER WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN IN METASTATIC BREAST-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 45-52

Authors: SORENSEN B BASTHOLT L MIRZA MR GJEDDE SB JAKOBSEN P MOURIDSEN HT ROSE C
Citation: B. Sorensen et al., THE CARDIOPROTECTOR ADR-529 AND HIGH-DOSE EPIRUBICIN GIVEN IN COMBINATION WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN - A PHASE-I STUDY IN METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 34(5), 1994, pp. 439-443

Authors: GJEDDE SB MOURIDSEN HT LMADSEN E JENSEN NV BLOMQUIST E BERGH J SODERBERG M WAHLBY S
Citation: Sb. Gjedde et al., PHASE-1 STUDY OF TAUROMUSTINE ADMINISTERED IN A WEEKLY SCHEDULE, European journal of cancer, 29A(13), 1993, pp. 1901-1902

Authors: PEDERSENBJERGAARD J GJEDDE SB PHILIP P RORTH M SIGSGAARD TC NIELSEN D HANSEN M DOMBERNOWSKY P LARSEN SO
Citation: J. Pedersenbjergaard et al., EPIRUBICIN AND THE RISK OF LEUKEMIA - NOT SUBSTANTIATED - REPLY, Journal of clinical oncology, 11(7), 1993, pp. 1432-1432
Risultati: 1-7 |